XML 42 R30.htm IDEA: XBRL DOCUMENT v3.20.2
Related Parties Transactions (Tables)
 9 Months Ended
Sep. 30, 2020
Related Party Transactions [Abstract]  
Schedule of related party transactions
Name of entity or Individual   Relationship with the Company and its subsidiaries
BioFirst Corporation (the "BioFirst")   Entity controlled by controlling beneficiary shareholder of YuanGene
BioFirst (Australia) Pty Ltd. (the "BioFirst (Australia)")   100% owned by BioFirst; Entity controlled by controlling beneficiary shareholder of YuanGene
Rgene Corporation (the "Rgene")   Shareholder of the Company; entity controlled by controlling beneficiary shareholder of YuanGene
YuanGene Corporation (the "YuanGene")   Controlling beneficiary shareholder of the Company
AsiaGene Corporation (the "AsiaGene")   Shareholder; entity controlled by controlling beneficiary shareholder of YuanGene
Eugene Jiang   Former President and Chairman
Keypoint Technology Ltd. (the "Keypoint')   The Chairman of Keypoint is Eugene Jiang's mother.
Lion Arts Promotion Inc. (the "Lion Arts")   Shareholder of the Company
Yoshinobu Odaira (the "Odaira")   Director of the Company
GenePharm Inc. (the "GenePharm")   Mr. George Lee, the Director and Chairman of Biokey, is the Chairman of GenePharm.
Euro-Asia Investment & Finance Corp Ltd. (the "Euro-Asia")   Shareholder of the Company
LBG USA, Inc. (the "LBG USA")   100% owned by BioFirst; Entity controlled by controlling beneficiary shareholder of YuanGene
LionGene Corporation (the "LionGene")   Shareholder of the Company; Entity controlled by controlling beneficiary shareholder of YuanGene
Kimho Consultants Co., Ltd. (the "Kimho")   Shareholder of the Company
Mr. Tsung-Shann Jiang, Ms. Shu-Ling Jiang, Mr. Chang-Jen Jiang, Ms. Mei-Ling Jiang, and Mr. Eugene Jiang (collectively the "Jiangs")   Mr. Tsung-Shann Jiang, the controlling beneficiary shareholder of the Company and Rgene, the Chairman and CEO of the BioLite Holding Inc. and BioLite Inc. and the President and a member of board of directors of BioFirst
 
Ms. Shu-Ling Jiang, Mr. Tsung-Shann Jiang's wife, is the Chairman of Keypoint, LION, and BioFirst; and a member of board of directors of BioLite Inc.
 
Mr. Eugene Jiang is Mr. and Ms. Jiang's son. Mr. Eugene Jiang is the chairman, and majority shareholder of the Company and a member of board of directors of BioLite Inc.
 
Mr. Chang-Jen Jiang is Mr. Tsung-Shann Jiang's sibling and the director of the Company.
 
Ms. Mei-Ling Jiang is Ms. Shu-Ling Jiang's sibling.
Amkey Ventures, LLC ("Amkey")   An entity controlled by Dr. George Lee, who serves as the Chairman of the board of directors of BioKey, Inc
BioLite Japan   Entity controlled by controlling beneficiary shareholder of
Schedule of accounts receivable due from related parties

   September 30,   December 31, 
   2020   2019 
GenePharm Inc.  $142,225   $142,225 
Rgene   1,053    1,053 
Amkey   2,800    - 
Total  $146,078   $143,278 
Schedule of amount due from related parties

   September 30,   December 31, 
   2020   2019 
Rgene  $40,709   $36,332 
AsiaGene   4,007    3,578 
BioFirst   -    137,151 
BioFirst (Australia)   367,361    40,000 
BioHopeKing Corporation   119,765    115,946 
LBG USA   675    675 
BioLite Japan   100,000    - 
Total  $632,517   $333,682 
Schedule of amount due to related parties

   September 30,   December 31, 
   2020   2019 
LionGene Corporation  $3,657   $10,275 
BioFirst Corporation   160,871    24,182 
AsiaGene   24,017    24,017 
YuanGene   9,205    9,205 
The Jiangs   26,449    40,031 
Kimho   13,000    21,500 
Euro Asia   30,000    12,000 
Due to shareholders   201,234    284,479 
Due to employees   72,433    – 
Total  $540,866   $425,689